期刊文献+

食管癌术后呼吸机相关性肺炎23例病原体及耐药性分析

Clinical analysis of patients with ventilator associated pneumonia after surgical treatment for esophageal carcinoma
原文传递
导出
摘要 目的 调查重症监护病房(ICU)应用人工气道进行机械通气的食管癌患者伴呼吸机相关性肺炎(VAP)的致病菌群及探讨治疗对策。方法 对23例建立人工气道的机械通气伴VAP的食管癌患者痰培养分离出的54株致病菌进行分析。结果革兰阳性菌占18.52%。革兰阴性菌占74.07%,分别列前2位的是铜绿假单胞菌(29.63%)、不动杆菌属(25.93%)。所有革兰阴性菌对抗菌药物的耐药率呈上升趋势,革兰阳性菌以耐药金葡菌为主(40%)。结论 食管癌患者术后VAP的致病菌多为耐药菌,为避免耐药率的升高,临床需要合理使用抗生素并给予患者综合治疗。 Objective To investigate the distribution and sensitivity of pathogenic bacteria in ventilator associated pneumonia (VAP) in the patients after surgical treatment for esophageal carcinoma and to explore the therapy. Methods In 23 patients, 54 strains of pathogens in VAP were classified and drug resistance was analyzed. Results Ten(18.52%) of 54 strains were gram positive bacilli,40 (74.07%) of 54 strains were gram negative bacilli. The predominant pathogens were pseudomonas aeruginosa (29.63%), acinetobacter baumanii (25.93%). Drug sensitivity test showed that the drug resistance rate was in an increasing tendency in pathogens. Among the gram positive bacteria, durg-resistant stapthylococcus aureus was the most common(40%). Conclusions The main pathogens are drug-resistant in VAP after surgical treatment for esophageal carcinoma. In order to control the drug resistance, reasonable application of antibiotics should be emphasized and patients should be treated synthetically.
出处 《国际呼吸杂志》 2007年第12期895-897,共3页 International Journal of Respiration
关键词 食管癌 呼吸机相关性肺炎 机械通气 Esophageal carcinoma Ventilator associated pneumonia Mechanical ventilation
  • 相关文献

参考文献7

二级参考文献41

  • 1Schurink K,Bonten M,VD Graaf E,et al. Albumen-α 2 microglobulin ratio in bronchoalveolar lavage fluid(BLAf) as a tool to diagnose ventilator associated pneumonia( VAP) .43rd IACCA Abstracts. Chigaco,2003,342:k126.
  • 2Diaz E, Rello J. Top ten list in antibiotic policy in the ICU. Chest,2002,122( 2): 712- 714.
  • 3Kollef MH. Empiric antibiotic selection and outcome in patients with suspected nosocomial pneumonia. Veterans Health System,1999,4( 1): 21- 28.
  • 4Timsit JF, Cheval C, Gachot B, et al. Usefulness of a strategy based on bronchoscopy with direct examination of bronchoalveolar lavage fluid in the initial antibiotic therapy of suspected ventilator- associated pneumonia. Intensive Care Med,2001,27(4):640
  • 5Mayhall CG. Ventilator- associated pneumonia or not? Contemporary diagnosis. Emerg Infect Dis, 2001,7(2):200- 204.
  • 6Sintchenko V,Iredell JR, Gilbert GL. Antibiotic therpy of ventilator- associated pneumonia- a reappraisal of rationale in the era of bacterial resistance. Int J Antimicrob Agents,2001,18(3):223- 229.
  • 7Rello J, Paiva JA, Baraibar J, et al. International Conference for the development of Consensus on the Diagnosis and Treatment of Ventilator- associated Pneumonia. Chest, 2001,120(3):955- 970.
  • 8Dupont H, Mentec H, Sollet JP, et al. Impact of appropriateness of initial antibiotic therapy on the outcome of ventilator- associated pneumonia. Intensive Care Med,2001,27(2):355- 362.
  • 9Iregui M, Ward S, Sherman G, et al. Clinical importence of delays in the initiation of appropriate antibiotic treatment for ventilator- associated pneumonia. Chest,2002,122(1):262- 268.
  • 10Fowler RA, Flavin KE, Barr J, et al. Variability of antibiotic prescribing patterns and outcome in patients with clinically suspected ventilator- associated pneumonia. Chest,2003,123(3):835- 844.

共引文献272

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部